Save the Date

Join us for our launch event February 9, 2017 Knight Conference Center at The Newseum 555 Pennsylvania Ave NW Washington, DC 20001 More Information and Registration Details Coming Soon

Highlights

Mark McClellan, MD, PhD, is co-chair of the National Academy of Medicine initiative, Vital Directions for Health and Health Care. Learn More Read the Commentary in JAMA

National Evaluation System for Health Technology (NEST) Planning Board: Coordinating Center to Prioritize Cooperative Projects The 25-member board, convened by the Duke-Margolis Center for Health Policy, is a broad-based group that includes patients, clinicians, the medical device industry, payers and regulatory experts, as well as five representatives from federal agencies. Learn More

New Guidelines Enhance Evidence-based Health Care In a special communication published September 13th in the Journal of the American Medical Association, a panel has updated 20-year-old guidelines and recommendations for evaluating cost-effectiveness in health and medicine. The panel was led by co-chairs Gillian D. Sanders, PhD, professor in the Duke Department of Medicine and a member of both the Duke Clinical Research Institute and the Duke-Margolis Center for Health Policy, and Peter J. Neumann, director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center.  Read the News Release Read the special communication in JAMA

News

Editorial Compares International Experiences in Risk-Benefit Analysis for Regulatory Decisions In a guest editorial in Value in Health, Shelby Reed, PhD, of Duke Clinical Research Institute and Gabriela Lavezzari, PhD, MBA, of Duke-Margolis provide an overview of the international regulatory experience in quantitative risk-benefit analysis. Read more A Call for Collaborative Action: Achieving Readiness for a Value Payment World  Governor Michael Leavitt and Duke-Margolis Director Mark McClellan, MD, PhD, co-chair the Accountable Care Learning Collective.  Read their Call for Collaborative Action. Partnership Chosen as HealthyCommunity50 Members Duke-Margolis, Durham County Department of Public Health and Cabarrus Health Alliance selected from hundreds of entries to compete for up to $500,000 in prizes through Aetna Foundation, American Public Health Association and National Association of Counties partnership.  Read more. Medicare Accountable Care Organization Results For 2015: The Journey To Better Quality And Lower Costs Continues Robert Saunders, PhD, and Mark McClellan, MD, PhD, of Duke-Margolis and Leavitt Partners' David Muhlestein comment on the Health Affairs Blog.

Experts

Greg Daniel, MPH, PhD, RPh, has been invited to give the keynote address, with Gabriela Lavezzeri, PhD, MBA, for the general assembly of the DRIVE-AB project, the public-private partnership funded by the Innovative Medicines Initiative and tasked with designing new economic models to stimulate antibiotic research and development based on innovation, access and sustainable use. The keynote will take place on October 17th in Oslo, Norway. Dr. Daniel will also give a keynote address at the Transcatheter Cardiovascular Therapeutics Meeting in Washington on October 31st, "National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions”. Mark McClellan, MD, PhD, will give a keynote address on "Reforming Medicare" on October 21st at the ACO & Emerging Healthcare Delivery Coalition's Fall Meeting in Philadelphia, PA.  On October 26th, Dr. McClellan will present the keynote at the Galien Foundation Forum in New York, NY.

Events

The Future of the U.S. Biosimilars Market: Development, Education, and Utilization October 18, 2016 -  9:00 am to 12:30 pm Friends of Cancer Research and the Duke-Margolis Center for Health Policy will convene a half-day forum bringing together clinicians, originator and biosimilar drug sponsors, advocates, regulators, and payers to tackle remaining uncertainty surrounding the future of the U.S. biosimilars market. Learn More and Register

Designing Economic Incentives for Antimicrobials: Implementation in the U.S. Context November 9, 2016 -  8:30 am to 3:30 pm Duke-Margolis is focused on advancing the development of innovative and accessible antimicrobials through the design and evaluation of sustainable economic incentives that reward effective drugs while also supporting stewardship. This public meeting will share research findings and preliminary policy recommendations from a July 2016 Expert Workshop with the broader stakeholder community and evaluate challenges to implementation. Learn More and Register

Connect with us!

About Duke-Margolis The Duke-Margolis Center for Health Policy's mission is to improve health and the value of health care by developing and implementing evidence-based policy solutions locally, nationally, and globally. Our work is focused on three themes: Health Care Delivery Biomedical Innovation Education and Workforce Development

Support Duke Margolis If you are interested in supporting health policy research at Duke University, visit our website. This newsletter is published monthly by the Robert J. Margolis, MD, Center for Health Policy at Duke University. Did you receive this newsletter from a friend?  Subscribe now.

Visit our website